Small cell lung cancer: an overview of the targets
Abstract Lung cancer is the leading cause of cancer deaths worldwide. Small cell lung cancer (SCLC) accounts for approximately 15% of all lung cancer cases. Despite a frequently good response to first-line treatment with chemotherapy and/or radiotherapy, early relapse occurs in the majority of patie...
Saved in:
Main Authors: | Bruna Nardy Valadares (Author), Marco Antonio Stephano (Author) |
---|---|
Format: | Book |
Published: |
Universidade de São Paulo,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An overview of mortality & predictors of small-cell and non-small cell lung cancer among Saudi patients
by: Hatim I. Alghamdi, et al.
Published: (2018) -
Inhaled Medicines for Targeting Non-Small Cell Lung Cancer
by: Arwa Omar Al Khatib, et al.
Published: (2023) -
Targeting glycolysis in non-small cell lung cancer: Promises and challenges
by: Jia-Qi Xu, et al.
Published: (2022) -
Recent progress in targeted therapy for non-small cell lung cancer
by: Yanxia Xiao, et al.
Published: (2023) -
Therapies Targeting Immune Cells in Tumor Microenvironment for Non-Small Cell Lung Cancer
by: Wei Ye, et al.
Published: (2023)